K-numberK241418
Device nameOptoMonitor 3
ApplicantOpsens, Inc.
Product codeDXO
Device classClass II
Decision dateFeb 12, 2025
DecisionSubstantially Equivalent
Regulation870.2870
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The OptoMonitor 3 is a catheter tip pressure transducer system that measures cardiovascular blood pressure in heart chambers, coronary vessels, and peripheral vessels during interventional procedures. It provides hemodynamic information including fractional flow reserve (FFR) for diagnosis and treatment of blood vessels, and valve gradients during transcatheter aortic valve (TAVI) procedures.

Technological characteristics

The device uses a fiberoptic sensor embedded in a guidewire to sense pressure, with a reusable signal processor and LCD monitor display. Operating specifications include a pressure range of -30 to 300 mmHg, accuracy of ±1 mmHg plus ±1-3% of reading, operating temperature 15-30°C, and electrical isolation Class 2 (double isolation). The primary change from the predicate is the addition of ARi and TIARi adjunctive hemodynamic indicators to the real-time numerical values and recording outputs.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

The device is substantially equivalent because it uses identical hardware components, system capabilities, pressure sensing technology, and operational specifications as the predicate OptoMonitor 3 (K213854). The only change is software-related: the addition of ARi/TIARi hemodynamic indicator display. Retrospective analysis of 30 pressure recordings from 10 patients demonstrated the calculated indices match literature formulas with Pearson correlations >0.99. A clinical annotation study of 420 waveforms showed high agreement (Bland-Altman analysis) between OptoMonitor 3 outputs and expert clinician annotations. Risk management identified no new safety or effectiveness concerns, with one pre-existing risk (suboptimal measurement conditions) deemed tolerable as benefits outweigh risks.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →